Antimuscarinic Toxicity Safely Managed with High-Dose Transdermal Rivastigmine: A Case Report
There is mechanistic plausibility supporting safe, sustained control of antimuscarinic toxicity with high-dose transdermal rivastigmine. Central distribution is more rapid than serum distribution and higher doses correlate with a shorter time to peak concentration.
Authors
- C. James Watson (ORCID: https://orcid.org/0000-0002-1003-5798)
- Emilie Burrill
- William S. Jaffee
Institutions
- Tufts University (US)
- Maine Medical Center (US)
- Maine Medical Center (US)
Publication Details
- Journal
- Clinical Practice and Cases in Emergency Medicine
- Published
- 2026-01-16
- DOI
- https://doi.org/10.5811/cpcem.49089
- Primary Topic
- Poisoning and overdose treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00